REQUEST A DEMO
Total
USD $0.00
Search more companies

Opakim Tibbi Urunler A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Opakim Tibbi Urunler Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

opakim a.s is a pharmaceutical company that specializes in the production and distribution of contrast substances used in medical imaging. opakim a.s is the representative of GE Healthcare's contrast agents in Turkey and has played a leading role in diagnosing diseases by importing the needed contrast agents in the country. Additionally, the company has started to produce contrast agents used in medical imaging in Turkey as part of the "Pharmaceutical Localization Project" of the Ministry of Health.

Headquarters
Kar Plaza Ic Kapi No:17 No:47 Icerenkoy Mahallesi Karaman Ciftlik Yolu Caddesi Atasehir
Istanbul; Marmara;

Contact Details: Purchase the Opakim Tibbi Urunler A.S. report to view the information.

Website: http://www.opakim.com.tr

Basic Information
Total Employees:
Purchase the Opakim Tibbi Urunler A.S. report to view the information.
Financial Auditors:
Purchase the Opakim Tibbi Urunler A.S. report to view the information.
Incorporation Date:
February 23, 1994
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Opakim Tibbi Urunler A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
68.13%
Total operating revenue
68.13%
Operating profit (EBIT)
18.19%
Net Profit (Loss) for the Period
-34.82%
Total assets
22.28%
Total equity
47.33%
Operating Profit Margin (ROS)
-8.28%
Net Profit Margin
-7.39%
Return on Equity (ROE)
-20.22%
Debt to Equity Ratio
-57.69%
Quick Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?